Cargando…
Circular RNA circFIRRE drives osteosarcoma progression and metastasis through tumorigenic-angiogenic coupling
BACKGROUND: Disappointing clinical efficacy of standard treatment has been proven in refractory metastatic osteosarcoma, and the emerging anti-angiogenic regimens are still in the infantile stage. Thus, there is an urgent need to develop novel therapeutic approach for osteosarcoma lung metastasis. M...
Autores principales: | Yu, Lingfeng, Zhu, Hao, Wang, Zhen, Huang, Jianhao, Zhu, Yan, Fan, Gentao, Wang, Yicun, Chen, Xi, Zhou, Guangxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389772/ https://www.ncbi.nlm.nih.gov/pubmed/35986280 http://dx.doi.org/10.1186/s12943-022-01624-7 |
Ejemplares similares
-
Identification of RALA as a Therapeutic Target and Prognostic Predictor of Osteosarcoma
por: Fan, Gentao, et al.
Publicado: (2023) -
PLOD2 high expression associates with immune infiltration and facilitates cancer progression in osteosarcoma
por: Wang, Zhen, et al.
Publicado: (2022) -
In vivo self-assembly and delivery of VEGFR2 siRNA-encapsulated small extracellular vesicles for lung metastatic osteosarcoma therapy
por: Yu, Lingfeng, et al.
Publicado: (2023) -
Circular RNA circ‐FIRRE interacts with HNRNPC to promote esophageal squamous cell carcinoma progression by stabilizing
GLI2 mRNA
por: Zhou, Yongjia, et al.
Publicado: (2023) -
LncRNA NDRG1 aggravates osteosarcoma progression and regulates the PI3K/AKT pathway by sponging miR-96-5p
por: Wang, Zhen, et al.
Publicado: (2022)